ALKERMES | Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 391.49B 12.34B 2026-02
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
ALKERMES USD 5.65B 696M 2026-02
Amgen USD 201.45B 25.2B 2026-02
Biogen USD 27.01B 1.19B 2026-02
BioMarin Pharmaceutical USD 11.99B 575M 2026-02
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Coherus Biosciences USD 278M 184M 2025-06
Eli Lilly USD 1.01T 3.37B 2026-02
Gilead Sciences USD 183.59B 31.31B 2026-02
Heron Therapeutics USD 145M 6M 2023-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
J&J USD 500.24B 67.44B 2025-12
Malin Corporation EUR 150.45M 12.13M 2026-01
Merck USD 300.37B 39.11B 2026-02
Minerva Neurosciences USD 43M 5M 2023-12
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 13.68B 465M 2026-02
Otsuka Holdings JPY 5.69T 867.19B 2026-02
Ovoca Bio EUR 7.54M 4.28M 2022-06
Pfizer USD 152.89B 11.32B 2026-02
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Vertex Pharmaceuticals USD 120.12B 5.09B 2026-02


ALKERMES Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.